Products for Research Use Only
RegisterLogin

ELQ-598

CAT: 0804-HY-163483Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-163483Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
ELQ-598, as a prodrug, is converted into the active drug ELQ-596 upon oral administration. ELQ-598 demonstrates potent parasitic growth inhibition capabilities (IC50= 37 nM) . ELQ-598 also shows low toxicity towards human cells (IC50= 19 μM) . ELQ-598 can be used for research into babesiosis[1].
CAS Number
3023709-99-8
UNSPSC
12352005
Target
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/elq-598.html
Solubility
10 mM in DMSO
Smiles
ClC1=CC2=C(N=C(C)C(C3=CC=C(C4=CC=C(OC(F)(F)F)C=C4)C=C3)=C2OCOC(OCC)=O)C=C1OC
Molecular Formula
C28H23ClF3NO6
Molecular Weight
561.93
References & Citations
[1]Vydyam P, et al. Effectiveness of Two New Endochin-like Quinolones, ELQ-596 and ELQ-650, in Experimental Mouse Models of Human Babesiosis. ACS Infect Dis. 2024 Apr 12;10 (4) :1405-1413.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-163482ELQ-596
HY-174343ELQ-121
HY-174342ELQ-453
HY-171190ELQ-316
HY-163484ELQ-650
HY-13836-01ELQ-300
HY-16343-01NB-598
HY-19546-01BAY-598
HY-W952826CRBN ligand-598
HY-19546A-01(R) -BAY-598

Alternative Products

CatalogName
T86364-01ELQ-598
BA2101-10ELQ-300
T86363-01ELQ-596
T210968-01ELQ-453
T210705-01ELQ-121
GTR19235406-01ELQ-650
A21234-50ELQ-300 50mg
A21234-10ELQ-300 10mg
A21234-5ELQ-300 5mg
A21234-25ELQ-300 25mg

Popular Products